Table 3 Proportion of patients with a prolonged dispensation (≥ 90 days supplied) at index fill by cardiac medication class according to Ontario Drug Benefit claims, stratified by intervention group and study period (pre- vs post-intervention)

Average (across classes)^a

50/967 (5.2%)

53/447 (12%)

46/620 (7.4%)

29/306 (9.5%)

Statins

132/775 (17%)

99/371 (27%)

97/517 (19%)

49/244 (20%)

Beta blockers

69/694 (9.9%)

52/322 (16%)

62/464 (13%)

31/223 (14%)

Angiotensin system inhibitors

73/501 (15%)

49/230 (21%)

53/356 (15%)

27/178 (15%)

Secondary antiplatelets

48/658 (7.3%)

44/326 (13%)

40/518 (7.7%)

27/266 (10%)